Understanding Your Wegovy or Mounjaro Treatment Options
Prescription Weight Loss: Wegovy or Mounjaro Mechanisms Explained
When evaluating Wegovy or Mounjaro for prescription weight loss, understanding their distinct mechanisms helps inform treatment decisions. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone GLP-1, reducing appetite and promoting satiety after smaller meals. Mounjaro utilises tirzepatide, a dual agonist targeting both GLP-1 and GIP receptors, potentially offering enhanced metabolic effects through this innovative dual-pathway approach. Both prescription-only medicines require clinical assessment to ensure appropriate candidacy.
The choice between Wegovy or Mounjaro often depends on individual response patterns, dosing preferences, and practical considerations like storage requirements. Wegovy follows a structured 20-week dose escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro typically escalates from 2.5mg to 15mg over 12-20 weeks. Both treatments work alongside lifestyle modifications and have demonstrated significant weight management outcomes in their respective clinical trials, though direct head-to-head comparisons remain limited.
Wegovy or Mounjaro Pricing: Transparent UK Costs and Bundle Options
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro prescription weight loss treatments with transparent, upfront costs. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 code for new customers), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient multi-dose packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99.
For patients requiring maintenance supply consistency, our Take-It-Slow bundles offer extended treatment security without repeated ordering. The Ultimate Stability Trio provides three months of 2.4mg maintenance doses for £649.99, ensuring uninterrupted treatment progression. Returning customers benefit from the DOSE25 discount code applied at checkout, whilst all orders include next-day cold-chain delivery to maintain medication integrity from our GPhC-registered pharmacy (#9012878).
Clinical Evidence: Wegovy or Mounjaro Trial Results and Efficacy
Clinical trials for both Wegovy and Mounjaro demonstrate substantial weight management outcomes when used alongside lifestyle interventions. In the STEP 1 trial, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, as reported by Wilding et al. in the New England Journal of Medicine, 2021. The STEP 5 trial confirmed sustained weight loss of approximately 15.2% at two years, supporting long-term treatment efficacy.
Mounjaro's SURMOUNT trials similarly showed significant weight reductions, though direct comparison between Wegovy or Mounjaro requires careful consideration of different trial populations and methodologies. Both treatments require individual assessment to determine expected outcomes, as clinical trial results reflect average responses in controlled study conditions rather than assured individual results.
How Wegovy Works: GLP-1 Mechanism for Prescription Weight Loss
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone GLP-1 that regulates appetite and food intake. When administered as a once-weekly injection, semaglutide activates GLP-1 receptors in the brain's appetite control centres, particularly the hypothalamus, reducing hunger signals and promoting feelings of fullness after smaller meals. This mechanism may help patients naturally consume fewer calories without the intense hunger often associated with caloric restriction. The medication also slows gastric emptying, prolonging satiety and potentially reducing food cravings between meals. Unlike stimulant-based appetite suppressants, Wegovy works through natural metabolic pathways, supporting sustainable appetite regulation when combined with dietary and exercise modifications.
Ordering Wegovy or Mounjaro: Streamlined Assessment Process
EverydayMeds simplifies access to both Wegovy and Mounjaro through our efficient three-minute online clinical assessment, designed to evaluate eligibility for prescription weight loss treatment. The assessment covers medical history, current medications, weight management goals, and contraindication screening to ensure safe prescribing practices. Following submission, our qualified prescribers review applications within standard three working days (or 24 hours with express service), conducting thorough clinical evaluation before authorising treatment. Once approved, medications are dispatched via next-day delivery using temperature-controlled packaging to maintain the cold-chain integrity essential for injectable medications. This streamlined process eliminates the need for face-to-face consultations whilst maintaining rigorous clinical oversight throughout your weight management journey.
Storage and Practical Considerations: Wegovy or Mounjaro Handling
Storage requirements represent a key practical difference when choosing between Wegovy or Mounjaro for ongoing treatment. Wegovy maintains stability for up to six weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for frequent travellers or those with limited refrigerator access. Both medications require initial storage at 2-8°C and utilise pre-filled FlexTouch injection pens for convenient once-weekly administration. The dose escalation schedule demands careful planning—Wegovy's five-dose progression over 20 weeks requires consistent supply management, whilst treatment interruptions may necessitate restarting at lower doses. Proper injection technique and rotation of injection sites (thigh, upper arm, or abdomen) helps minimise injection site reactions and ensures optimal medication absorption.
Wegovy or Mounjaro: Personalising Your Weight Management Strategy
Selecting between Wegovy or Mounjaro requires individualised assessment of medical history, lifestyle factors, and treatment preferences rather than a one-size-fits-all approach. Patients with type 2 diabetes may benefit from either medication's glucose-lowering effects, though Mounjaro's dual-agonist mechanism may offer additional metabolic advantages in this population. Those prioritising treatment convenience might prefer Wegovy's superior storage flexibility, whilst patients seeking the latest therapeutic innovation may gravitate toward Mounjaro's unique dual-pathway approach.
Cost considerations, insurance coverage, and long-term treatment sustainability also influence the decision between Wegovy or Mounjaro. Both medications require ongoing commitment to dietary modifications and physical activity, as weight regain typically occurs following treatment discontinuation. The STEP 1 extension trial demonstrated that patients regained approximately two-thirds of lost weight within one year of stopping Wegovy, emphasising that weight management represents a long-term health commitment rather than a temporary intervention.
Start Your Weight Loss Journey: Wegovy or Mounjaro Available Now
Both Wegovy and Mounjaro are immediately available through EverydayMeds' comprehensive weight management programme, supported by our GPhC-registered pharmacy operations (#9012878) and qualified prescriber network. New customers can begin their assessment today using discount code FIRST40, whilst returning patients benefit from DOSE25 savings applied automatically at checkout. Our clinical team provides ongoing support throughout your treatment journey, monitoring progress and adjusting therapy as needed to optimise outcomes. Whether you choose Wegovy's established GLP-1 approach or Mounjaro's innovative dual-agonist mechanism, both treatments offer evidence-based pathways to sustainable weight management when combined with lifestyle modifications. Begin your three-minute assessment at https://everydaymeds.co.uk/collections/wegovy to determine which prescription weight loss treatment aligns with your health goals and start your transformation with professional medical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
